IMEIK

300896

Current ValuationThe current P/E ratio is 27.17, within the reasonable range, cheaper than 71.7% of the time in the past 3 years, and the industry ranks 9/84, the industry Median 20.41.

27.17xP/E
Stock price¥88.78Earnings per share¥3.27

Historical Valuation

P/E ratioTypical rangeMedian

Peer P/E ratio Comparison

It displays how the company's P/E ratio compares to top companies within its industry.
Industry median 20.41x
022446688

Industry P/E ratio Comparison

This shows the distribution of companies by P/E ratio range and their projected earnings per share growth for the next fiscal year.
Industry median 20.41x
0x40x80x120x160x200x
P/E ratio
Name/Symbol
688428SHInnoCare
30.82x10.53%¥41.99B
603087SHGan & Lee
34.91x23.32%¥41.31B
002252SZShanghai RAAS
29.77x16.67%¥32.30B
300896SZIMEIK
27.17x11.31%¥26.86B
600161SHBTBP
36.18x29.09%¥25.33B
002007SZHUALAN BIOLOGICAL
38.94x1.31%¥22.84B
688266SHZelgen
38.90x399.46%¥22.12B
688278SHAMOYTOP
21.69x19.44%¥18.27B
301301SZYili Chuanning Bio
34.30x5.88%¥16.81B
300009SZANKE BIO
20.41x6.82%¥13.30B
300685SZAmoyDx
21.78x1.11%¥7.53B
300406SZBSBE
29.33x121.88%¥7.35B
300841SZKanghua Biological
25.20x22.92%¥6.50B
002880SZWEIGUANG BIOLOGICAL
26.64x20.82%¥4.52B
300439SZMedicalsystem
37.77x--¥3.80B
300653SZZHBIO
39.07x20.65%¥2.49B

Risk Warning

Timeframes using financial data from S&P Global. The feature provides key metrics such as price-to-earnings (P/E), price-to-book (P/B), price-to-sales (P/S) ratios, and dividend yield. For reference only and does not constitute investment advice.